M&T Bank Corp lessened its stake in Koninklijke Philips (NYSE:PHG – Free Report) by 4.4% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,117 shares of the technology company’s stock after selling 598 shares during the period. M&T Bank Corp’s holdings in Koninklijke Philips were worth $429,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds also recently made changes to their positions in the company. Fairscale Capital LLC acquired a new stake in shares of Koninklijke Philips in the 2nd quarter valued at about $54,000. Eastern Bank purchased a new stake in Koninklijke Philips in the third quarter valued at approximately $88,000. Blue Trust Inc. lifted its stake in Koninklijke Philips by 902.7% in the second quarter. Blue Trust Inc. now owns 3,700 shares of the technology company’s stock valued at $93,000 after buying an additional 3,331 shares during the last quarter. RPg Family Wealth Advisory LLC acquired a new stake in shares of Koninklijke Philips in the third quarter valued at approximately $107,000. Finally, Allspring Global Investments Holdings LLC grew its position in shares of Koninklijke Philips by 182.4% during the second quarter. Allspring Global Investments Holdings LLC now owns 5,657 shares of the technology company’s stock worth $143,000 after acquiring an additional 3,654 shares during the last quarter. Hedge funds and other institutional investors own 13.67% of the company’s stock.
Koninklijke Philips Stock Performance
NYSE:PHG opened at $24.71 on Thursday. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.16 and a quick ratio of 0.74. The firm has a market cap of $23.23 billion, a price-to-earnings ratio of -58.83, a price-to-earnings-growth ratio of 0.92 and a beta of 0.76. The firm’s fifty day moving average price is $27.72 and its 200 day moving average price is $28.16. Koninklijke Philips has a 1-year low of $19.55 and a 1-year high of $32.91.
Analyst Ratings Changes
Check Out Our Latest Research Report on Koninklijke Philips
Koninklijke Philips Company Profile
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Read More
- Five stocks we like better than Koninklijke Philips
- How to Invest in Biotech Stocks
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- Why is the Ex-Dividend Date Significant to Investors?
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- How to Calculate Options Profits
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Want to see what other hedge funds are holding PHG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Koninklijke Philips (NYSE:PHG – Free Report).
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.